Sign in

Eva Garmendia

@evagaresp.bsky.social
1.2K followers 392 following 96 posts

Science and photography. Coordinator and communicator at the @uac-uu.bsky.social at Uppsala University. Host of #theAMRstudio podcast. COO of RxDynamics. #scicomm & #outreach advocate. After the hows & whys. 👉🏻 linktr.ee/evagaresp

PostsRepliesMedia
Eva Garmendia @evagaresp.bsky.social · 04/03/2026
To mark 8 years at the @uac-uu.bsky.social, I wrote down some thoughts about tackling antibiotic resistance and its impact. Short version: it's everyone's problem, and no single discipline is going to fix it alone. Long version: go read the editorial! 😄 www.pathogens.se/editorials/u...
pathogens.se
Antibiotic resistance does not recognise disciplinary borders: The Uppsala Antibiotic Center’s approach to research and education
Building a cross-disciplinary and intergenerational community of scholars to confront antibiotic resistance.
020
Eva Garmendia @evagaresp.bsky.social · 04/06/2025
Thank you to all the amazing, bright and hardworking participants of #SciCommUU25!! You guys were brilliant, it was a pleasure to organize and deliver these three days to you. Can’t wait to see all the ways you’ll make this world better with your science and your communication! ☀️
161
Eva Garmendia @evagaresp.bsky.social · 04/06/2025
Final day of #SciCommUU25 comes in hot with Adeline Marcos from FECYT, bringing us the world of science journalism. How do science becomes news? The students had their own take on it covering the project EcoSentinel, which looks into enhancing plants to become nature’s guardians 🌿🌱 ecosentinel.eu
140
Eva Garmendia @evagaresp.bsky.social · 03/06/2025
Day 2 starting with an exploration of different #outreach opportunities around Uppsala, Sweden and beyond! We’ve talked about: 📚School visits 🔬SciFest 🍺Pint of Science 📰Opinon pieces 👩🏻‍🏫 European Researches Night 🏆Researches Grand Prix ☕️Science Fika 🎧Fikademia Podcast 🧼SoapBox Science #ScicommUU25
110
Eva Garmendia @evagaresp.bsky.social · 02/06/2025
Starting the 10th year sharing our love for #scicomm & #outreach at Uppsala University with our graduate course. 3 days full on ways to talk about science, how to reach different audiences, & how make research have the impact it needs in our societies. Here @hugogdtc.bsky.social kicking it off!
152
Eva Garmendia @evagaresp.bsky.social · 22/05/2025
I did it! Gave my first-ever #PintofScience talk at a pub in Stockholm! 🍺 Less data, more punchlines (well, attempted 😅). Feeling like a beginner again! The crowd was sharp, curious, and full of great questions. Grateful to have shared the night with brilliant speakers and an even better audience!
040
Eva Garmendia @evagaresp.bsky.social · 21/05/2025
On the way and ready to join Stockholm’s @pintsworld.bsky.social festival to talk about #AntibioticResistance! This time I feel like a beginner again by doing a new kind of talk… maybe with one or two jokes in there?? We will see… EXCITING!!!
220
Eva Garmendia @evagaresp.bsky.social · 14/04/2025
So well said! Both encouraging because of the opportunities but so discouraging to see we are just not doing enough. #ESCMIDGlobal
041
Eva Garmendia @evagaresp.bsky.social · 14/04/2025
What if instead of vilifying over-the-counter #antibioticprescription we taught and educated those potential sellers? @marcmendelson.bsky.social holds the difficult position of arguing against #newantibiotics, but greatly highlights all other aspects that require our attention #ESCMIDGlobal
022
Eva Garmendia @evagaresp.bsky.social · 14/04/2025
Day 4 and still touching on new topics! Now #probiotics on the scene. Lena Biehl brings evidence of their use for different indications. What’s promising: - use during (not before, not after!) #ab treatment to prevent diarrhea - vaginal use for #UTI, #candidiasis & #vaginosis #ESCMIDGlobal
011
Eva Garmendia @evagaresp.bsky.social · 14/04/2025
515.000 deaths, 2.5billion antibiotic doses, and A LOT of money can be saved by vaccination. Mateusz Hasso from @who.int makes a case for widespread immunization to reduce #AMR burden. Here’s the report: www.who.int/publications... #ESCMIDGlobal
031
Eva Garmendia @evagaresp.bsky.social · 14/04/2025
Vaccines are undoubtedly a way to manage #AMR, directly and indirectly! Adam Cunningham talks benefits and challenges. Vaccination to both #bacteria & #viruses reduces infection, disease burden & #antibiotic use! #ESCMIDGlobal
152
Eva Garmendia @evagaresp.bsky.social · 14/04/2025
Fusariosis can be as scary as it sounds. Fungal infections might not be as common as bacterial, but when they do happen their #resistance patterns can look like this! 😱 Thanks to @olivercornely.bsky.social for bringing us the new #antifungals coming to the rescue! #ESCMIDGlobal
054
Eva Garmendia @evagaresp.bsky.social · 14/04/2025
4th day starts with the #antibiotic pipeline. New drugs for our bugs! Martin Emting develops synthetic antivirulence molecules, aka pathoblockers 🙅🏻‍♀️ These drugs can stop bacteria from infecting by targeting systems like quorum sensing (bacterial communication!). #ESCMIDGlobal
151
Reposted by Eva Garmendia
Gabriele Pollara @gpollara.bsky.social · 12/04/2025
Just made a custom feed that pulls in a wide array of hashtags being used at ESCMID Global 2025 May have a few minutes delay, but contains posts with #ESCMIDGlobal #ESCMIDGlobal2025 #ESCMID2025 #ECCMID2025 Feel free to pin it to your timelines. Hope it's helpful #IDSky bsky.app/profile/did:...
55420
Eva Garmendia @evagaresp.bsky.social · 13/04/2025
Tender schnitzels, warm apple strudels, the fluffiest whipped cream you’ll ever find, sausages that keep on giving, or famous fancy cakes… Each #ESCMIDGlobal is an opportunity to explore a new cuisine, and #Viennese food does not disappoint! Anything else you might recommend? 2 days left! Ñam 🤤
290
Eva Garmendia @evagaresp.bsky.social · 13/04/2025
How to leverage #free-text data in GP health records? Gjis Danoe presents the BERT&EARNIE #AI driven #surveillance approach. Model can pick up signals of early outbreaks! Great potential for well organized #healthcare settings, where records are routinely gather! #ESCMIDGlobal
011
Eva Garmendia @evagaresp.bsky.social · 13/04/2025
Couldn’t agree more with @teachepi.bsky.social! Communication is vital, essential, NEEDED for progress! #comms skills should be as important as any other lab skill for scientists, but specially for those working in topics that relate directly with the public #ESCMIDGlobal
042
Eva Garmendia @evagaresp.bsky.social · 13/04/2025
Final notes on how to address anti-science. Be open, take it seriously and TAKE ACTION! #ESCMIDGlobal
042
Eva Garmendia @evagaresp.bsky.social · 13/04/2025
How can we break the **really bad** #sciencenews cycle that ends undermining the power and value of scientific progress? We scientists can help on #scicomm part of it, but little power over click-bait journalism & internet spread. @phdcomics.bsky.social phdcomics.com/comics/archi... #ESCMIDGlobal
041
Eva Garmendia @evagaresp.bsky.social · 13/04/2025
Listening to the great @marionkoopmans.bsky.social at a #ESCMIDGlobal session on #anti-science and trust in science. The public seems to agree with scientists needing to communicate to general audiences, but not so clear when asked if they should advocate or influence #policy. Why would this be?
161
Eva Garmendia @evagaresp.bsky.social · 13/04/2025
Emre Iseri from Utilizer present their method, based on a chromogenic agar on a dipstick, marrying the traditional culture method with the urine analysis tests. Easy, simple and quick to give results. #ESCMIDGlobal
131
Eva Garmendia @evagaresp.bsky.social · 13/04/2025
Patrice Nordmann brings us their cheap, easy & rapid test to detect #betalactamase activity in urine samples from #UTI patients. The test is based on Nitrocefin, which changes color if hydrolized when the enzymes are present. The hope is to bring it directly to the doctors office #ESCMIDGlobal
053
Eva Garmendia @evagaresp.bsky.social · 13/04/2025
In the wake of deploying new agents like new #metalobetalactamaseinhibitors, new tests look to find their usability from the get go, as resistance to these compounds can be already out there. Octavio Raro presents the NitroSpeed Taniborbactam platform based on hydrolization #ESCMIDGlobal
021
Eva Garmendia @evagaresp.bsky.social · 13/04/2025
Christian Moguet brings their lateral flow test to detect DHA AmpC #betalactamase in enterobacterales. Current work shows that the test has high sensitivity and can differentiate between low and high expression of the enzyme, which correlates with resistance phenotype #ESCMIDGlobal
021
Eva Garmendia @evagaresp.bsky.social · 13/04/2025
Starting the third day with #rapidAST. What’s new trying to get faster AND better? Julia Rogers presents a new lateral flow test that can detect the presence of an important betalactamase: KP2 #carbapenemase Test like this would be incredibly helpful in low-resource settings!
021
Eva Garmendia @evagaresp.bsky.social · 12/04/2025
The past, present and future? of #theAMRstudio podcast right before the #scicomm & #podcasting session at #ESCMIDGlobal So great to see the inspiring stories of @idiots-pod.bsky.social & Breakpoints @erinmccreary.bsky.social, examples to follow!
282
Eva Garmendia @evagaresp.bsky.social · 12/04/2025
Sights of #ESCMIDGlobal “Did the dinosaurs suffer from infections?”
020
Eva Garmendia @evagaresp.bsky.social · 12/04/2025
Colleague Sheida Heidarian presenting her e-poster on #hereroresistance on #enterococcus. Mainly found for gentamicin, daptomycin through point mutations & for tigecycline via gene amplification. #ESCMIDGlobal
111
Reposted by Eva Garmendia
Paul Sax @paulsaxmd.bsky.social · 12/04/2025
Remember ICAAC? Bad name, weirder pronunciation ("ick-kack"), ugly swag, and a classic case study in conference identity crisis. A look back—and where the big ID trials land now, which is #ESCMID Global, or whatever it's called. #IDSky blogs.jwatch.org/hiv-id-obser...
blogs.jwatch.org
Looking Back at a Defunct ID Meeting -- and Ahead to a Thriving One
Back in prehistoric times, many ID doctors and microbiologists would gather each fall at a meeting to review the latest antimicrobial clinical trials and promising “bug-drug” studies of novel compound...
10316
Eva Garmendia @evagaresp.bsky.social · 12/04/2025
Patient-centric view of #uUTI at the GSK integrated symposium. As a woman that has had recurrent UTIs in her youth, I love this take! I agree wholeheartedly with all these points, which can be reached if doctors would have more time for each patient! Btw, pivmecillinam is THE BEST! #ESCMIDGlobal
001
Eva Garmendia @evagaresp.bsky.social · 12/04/2025
When normal traditional #phagetherapy via phage isolation proves to be difficult… is there other way? Panos Kalatzis presents a tripartite strategy that includes also lysis from prophages, and endolysins to target #ESCMIDGlobal
141
Eva Garmendia @evagaresp.bsky.social · 12/04/2025
How to treat a rather pesty microbe like #mycobacterium? Gregory Phelps brings us a phenicol prodrug with a new mechanism of action that exploits intrinsic resistance and that shows collateral sensitivity for standard of care drugs. #ESCMIDGlobal
111
Eva Garmendia @evagaresp.bsky.social · 12/04/2025
Innovative #therapeutics! First up the use of mRNA platforms to deliver monoclonal antibodies for treatment! Successful production and titers! #ESCMIDGlobal
001
Eva Garmendia @evagaresp.bsky.social · 12/04/2025
So… this year’s #ESCMIDGlobal app. Constructive criticism, let’s go! 1. Don’t bring us back to main menu just because we go check other apps! 2. Don’t add suggestions to our agendas by default, and DO NOT restore that filter once I’ve disable it! 3. Don’t open my agenda from a day in the past… 😓
140
Eva Garmendia @evagaresp.bsky.social · 11/04/2025
Sights of #ESCMIDGlobal. “The in between”
010
Eva Garmendia @evagaresp.bsky.social · 11/04/2025
A new one for me! Using #phagetherapy for #UTI treatment. Here Saima Aslam present the reasoning for this, and some pointers how to organize #clinicaltrials centering the outcomes more towards the patient. Will this kind of therapy be reality in the coming decade? #ESCMIDGlobal
143
Eva Garmendia @evagaresp.bsky.social · 11/04/2025
Sometimes I wish I had about 8 arms and a couple more eyes to keep track of it all 🤣 🕷️ Having fun tho!
010
Eva Garmendia @evagaresp.bsky.social · 11/04/2025
Impressive collection of examples by the #PhageinLyon program helping >100 patients in their bone & join infection clinic, presented by Tristan Ferry Phages are specially good in these cases because they can target #biofilms effectively, and work in synergy with #antibiotics #ESCMIDGlobal
055
Eva Garmendia @evagaresp.bsky.social · 11/04/2025
Phage clinical rounds! Albeit being still difficult to regulate & use it broadly, #phagetherapy can be incredibly useful in some cases. Today we saw examples of a person recovery after 600days of hospitalization, and the #Achromophage trial, aiming to gather evidence for further use. #ESCMIDglobal
061
Eva Garmendia @evagaresp.bsky.social · 11/04/2025
C. Morel comes in like a storm with a paradigm change for us in #AMR and policy. What are we really implying but not saying, beyond all our “micro” talk? TREATABILITY! With it we can have a single actionable & measurable target, getting us closer to effectively reduce #AMR impact. #ESCMIDGlobal
011
Eva Garmendia @evagaresp.bsky.social · 11/04/2025
To start with Joseph Lewnard presents recent data that models and reviews HOW MUCH we could reduce #AMR deaths in #LMICs just applying properly what’s already available: 😷 infection prevention & control 💦🧼 water, sanitation & hygiene 💉 vaccines A WHOLE 10%! #ESCMIDGlobal
021
Eva Garmendia @evagaresp.bsky.social · 11/04/2025
As a 3-year tradition now, #ESCMIDGlobal is hosting a science-policy forum, with #AMR at the center of it all. At the last #UNGA in September a new declaration was signed up, with specific targets set. But will action follow? @drtedros.who.int from @who.int opens the forum with a call for action.
051
Eva Garmendia @evagaresp.bsky.social · 11/04/2025
Sights of #ESCMIDGlobal. “Nobody hears us scream”
ESCMID global art gallery
031
Eva Garmendia @evagaresp.bsky.social · 11/04/2025
Starting #ESCMIDGlobal in this #EducationalFriday (confusing, btw!!) talking #riskcommunications. @mariusgilbert.bsky.social bring us his experience jumping directly into the pool of #scicomm during #covid19. “Science as a narration” - such a good take! 👏🏻👏🏻
Conference speaker
003
Eva Garmendia @evagaresp.bsky.social · 11/04/2025
Ready to rock & mingle!!! Arriving to #ESCMIDglobal every year feels a bit like Christmas! 🎄 loads of plans, anticipation and fun! Hope to catch up with many of you over these 5 days!! Wait… 2027 Stockholm!!?? 😱
Eva at ESCMID global Sign at ESCMID
1100
Eva Garmendia @evagaresp.bsky.social · 03/02/2025
It is always such a pleasure to learn by interviewing the amazing people working to understand this world we live in. In this conversation we talk everything from birds 🐥, dinosaurs 🦕, travels 🌎 and of course #AMR! 🦠 Tune in: bit.ly/AMRep58
021
Eva Garmendia @evagaresp.bsky.social · 23/01/2025
Yes yes yes!!! So looking forward to work with all the new people that is now able to join us!
010
Eva Garmendia @evagaresp.bsky.social · 20/12/2024
yeah yeah yeah!!!! we are ready for another 4 years of helping build the future #AMR researchers, so our future has a way to treat as many #infections as possible! What a great christmas treat! 🎄 Can’t wait!!!
030
Eva Garmendia @evagaresp.bsky.social · 12/12/2024
Last episode for 2024 for #theAMRstudio! Currently working on the great lineup of guests for 2025, can’t wait!!
010